Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
*Proteasome subunit alpha 2 pseudogene 2* (PSMA2P2) is a **processed pseudogene** derived from the functional proteasome subunit alpha type-2 gene (PSMA2). Pseudogenes are segments of DNA that resemble functional genes but have lost their coding or regulatory capability to produce functional proteins. PSMA2P2 is not translated into a functional protein, has no known biological activity, and is not recognized as a therapeutic target. Such pseudogenes are common in mammalian genomes due to retrotransposition events, and generally do not result in active molecules, disease relevance, or therapeutic interest[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome subunit alpha 2 pseudogene 2 (PSMA2P2).